Skip To The Main Content
2020ATMPs-1988x680

PDA Webinar: Applying the Lifecycle Approach to Develop a Control Strategy for ATMPs (Part 2)

Journey Down a New Road to an Unfamiliar Destination

Jun 04, 2020
11:00 AM
-
1:00 PM
| Eastern Standard Time
Online
  • Virtual
  • Conference
  • Online

Overview

Part two of this webinar series will build upon the foundation presented in Part 1. Come away with the knowledge and skillset you need to utilize best practices when considering autologous and allogeneic products. Cell and gene therapy experts will cover critical quality attributes (CQA), critical product parameter (CPP), and critical material attributes (CMA). If your role focuses on cell therapy control strategy, don’t miss out on this specialized webinar.

This webinar is presented as part of the 2020 PDA Advanced Therapy Medicinal Products Month webinar series.

Highlighted Speakers

Michael N. Blackton
Michael N. Blackton
Adaptimmune LLC
Irving Ford
Irving Ford
Bristol-Myers Squibb
Melissa Gosse
Melissa Gosse
SwanBio Therapeutics, Inc
Darius D. Pillsbury
Darius D. Pillsbury
Valsource LLC

Registration Fees

Register Now
Registration Type Price
Member $200
Non-member $200
Gov't/Health Auth./Academic $200
Webinar Series Bundle* $1,500
Group Registration Bundle** $1,000

*Register for all 9 webinars in the Advanced Therapy Medicinal Products Month webinar series.

**Cost per person when you register 10 or more employees from the same company for all nine webinars in the Advanced Therapy Medicinal Products Month webinar series. Inquire now.

Got a Question? We have answers

Contact Us
Become a Sponsor

Interested in becoming a sponsor? Learn about opportunities and benefits.

Request Information

Exhibitors

Become an Exhibitor

Interested in becoming an exhibitor? Learn about opportunities and benefits.

Request Information

Attendee List Email Scam

Unfortunately, emails are circulating that offer to sell attendee lists for many of PDA’s conferences and events. These emails are sent by scammers.

Note: PDA does not sell its exhibitor or attendee lists, and no third-party is authorized to distribute or sell any lists related to our events. Statements claiming to offer our attendee lists are fraudulent. If you receive emails that propose to sell PDA conference attendee lists, do not engage with the sender and delete the message immediately.

Media Partners

PDA Members Save Substantially